Marco Legal De La Diabetes En Mexico

In this sense, it is relevant and necessary that the distinction between DM1 diabetes and other types of diabetes be clearly defined in the law. For this reason, this initiative proposes to add an article 159bis to the General Health Law (LGS) in order to guarantee patients with DM1 the right to health protection, as set out in Article 4 of our Political Constitution and the international treaties to which Mexico is a party. If the proposed addition is not made, the Mexican State would be violating the provisions of national legislation and the provisions agreed in the CRC and other instruments of international law, according to the following considerations: The World Health Organization (WHO) estimates that the number of people with diabetes increased from 108 million in 1980 to 422 million in 2016 [*]; Of the 56.4 million deaths recorded worldwide in 2016, the number of deaths from diabetes, which was less than one million in 2000, reached 1.6 million in 2016. This proposal prioritises outcome-oriented diabetes prevention and control measures that Member States can implement even in resource-limited environments. It is particularly important to emphasize that article 3 of the LGDNNA stipulates that the Federation, the federal authorities, the municipalities and the territorial limits of Mexico City agree to design, implement, monitor and evaluate public policies aimed at exercising, respecting, protecting and promoting the rights of children and adolescents and ensuring their greatest well-being through the privilege of the best interests of the child by measurements. Structural, legal, administrative and budgetary reasons, fundamental to add LGS to the benefit of patients with DM1. From all of the above, it is important to add a provision such as that proposed in the LGS with respect to MD1, as our legal framework for diabetes is currently not sufficiently specialised or specific to ensure unrestricted access to the health services and medical care that patients need. This is the case of the official Mexican standard NOM-015-SSA2-2010 for the prevention, treatment and control of diabetes mellitus, published in the Official Journal of the Federation (DOF) on 23 November 2010. [*] www.who.int/topics/diabetes_mellitus/es/ VII. The detection, diagnosis, treatment and control of type 1 diabetes mellitus through the publication of an official Mexican standard, a specific action programme and surveillance, surveillance and evaluation activities for this disease in accordance with Article 159a. In the case of DM1, there is only a quick guide for the diagnosis, treatment and rapid referral of type 1 diabetes mellitus in children and adolescents at the second and third levels of care, and there are specific guidelines for diabetes mellitus at the first level of care. Type 1 diabetes mellitus (DM1), also called insulin-dependent, juvenile or infantile, is characterized by low or no insulin production or synthesis and requires daily administration of this hormone, vital because it regulates the presence of sugar in the blood [*], while people with DM1 require lifelong insulin injections. The 2007-2012 Health Sector Program also did not establish a specific care component for MD1.

Its objectives include the reduction of diabetes mellitus, the reduction of its mortality rate and the promotion of a comprehensive policy of prevention and control, without specifying the nature of the disease. In the case of NOM 015 and the sectoral programme, the lack of special attention to DM1 violates the provisions of Articles 1, 2 and 3 of the LGDNNA and violates the principles contained in this General Law. Although T1D typically accounts for only a minority of the total burden of diabetes, it is the predominant form of the disease in most developed countries in the younger population and has a major impact on patients` quality of life, life expectancy and self-esteem. The reasons for the increase in diabetes in children and adolescents (DM1) are currently uncertain. Over time, this condition can cause damage to the heart, blood vessels, eyes, kidneys and nerves, even causing the onset of chronic problems and causing premature death in children and adolescents. It is this kind of suffering that is the subject of this initiative.